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ORIGINAL ARTICLECartilage Oligomeric Matrix Protein Negatively
Influences Keratinocyte Proliferation via a5b1-
Integrin: Potential Relevance of Altered
Cartilage Oligomeric Matrix Protein Expression
in Psoriasis
Renáta Bozó1, Edit Szél1, Judit Danis1,2, Barbara Gubán1, Zsuzsanna Bata-Csörg}o1,2, Kornélia Szabó1,2,
Lajos Kemény1,2,3 and Gergely Groma1,2In psoriasis, nonlesional skin shows alterations at the dermaleepidermal junction compared with healthy skin.
Cartilage oligomeric matrix protein (COMP) is part of the papillary dermis of healthy skin, and its expression
has not yet been studied in psoriatic skin. In this study, we found that COMP localization extended deeper into
the dermis and formed a more continuous layer in psoriatic nonlesional skin compared with healthy skin,
whereas in psoriatic lesions, COMP showed a partially discontinuous deposition at the dermaleepidermal
junction. COMP and b1-integrin showed strong colocalization in nonlesional skin, where the laminin layer
within the basement membrane is discontinuous. In in vitro models, the presence of exogenous COMP
decreased the proliferation rate of keratinocytes, and this proliferation-suppressing effect was diminished by
blocking a5b1-integrin. Our results suggest that COMP can interact with a5b1-integrin of basal keratinocytes
through the disrupted basement membrane, and this interaction might stabilize the epidermis in the nonle-
sional state by contributing to the suppression of keratinocyte proliferation. The antiproliferative effect of
COMP is likely to be relevant to other skin diseases in which chronic nonhealing wounds are coupled with
massive COMP accumulation.
Journal of Investigative Dermatology (2020) 140, 1733e1742; doi:10.1016/j.jid.2019.12.037INTRODUCTION
The pathogenesis of plaque-type psoriasis (Psoriasis vulgaris)
is only partially understood, and only symptomatic treatment
is currently available. In addition to hyperproliferation,
altered keratinocyte differentiation, and massive immune cell
infiltration, the dermal extracellular matrix (ECM) and the
basement membrane (BM) are also affected in healthy-
looking nonlesional skin of patients (Bata-Csorgo et al.,
1998; Glinski et al., 1993; Mondello et al., 1996; Vaccaro
et al., 2002). Nonlesional epidermal keratinocytes have
been shown to represent a preactivated state for hyper-
proliferation (Chen et al., 2001); these cells are more sensi-
tive to stress (Szabó et al., 2014) and to proliferative signals
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attachment modulator fibronectin (FN), which is differentially
expressed in nonlesional skin. Previously, we found that fi-
broblasts as well as basal keratinocytes express high levels of
the FN splice variant that contains the extra domain A (EDA þ
FN) in nonlesional skin (Gubán et al., 2016; Széll et al.,
2004). Moreover, some integrins, including the FN-
interacting a5b1-integrin, also exhibit an increased expres-
sion (Bata-Csorgo et al., 1998; Gubán et al., 2016) in kera-
tinocytes at the dermaleepidermal junction (DEJ). The
enhanced EDA þ FN and a5b1-integrin production that we
observed in psoriatic nonlesional skin may contribute to the
induction of keratinocyte proliferation (Bata-Csorgo et al.,
1998, 1995; Széll et al., 2004). Furthermore, at the DEJ in
nonlesional skin, the laminin layer of the BM is discontinuous
and the connection of keratinocytes to the BM is also altered
(McFadden and Kimber, 2016; Mondello et al., 1996).
Cartilage oligomeric matrix protein (COMP) is a non-
collagenous glycoprotein component of the ECM. The flex-
ible structure of the COMP homopentamer allows
simultaneous interactions with multiple cellular and extra-
cellular components (Malashkevich et al., 1996; Mörgelin
et al., 1992). COMP is mainly deposited in cartilage, but it
is also located in tendons, ligaments, synovium, and skin. In
addition, it is expressed in vascular smooth muscle cells,
cardiomyocytes, and activated platelets (Müller et al., 1998;
Posey et al., 2018; Tan and Lawler, 2009; Wang et al.,estigative Dermatology. www.jidonline.org 1733
Figure 1. COMP level is elevated in
psoriatic nonlesional skin. (a) COMP
protein was detected with western
blot analysis from healthy, psoriatic
nonlesional, and lesional skin. Actin
was used as a loading control. A
representative blot is shown under
reducing condition. (b) Band
intensities of COMP monomer were
quantitated with Image Studio
software (LI-COR Biosciences,
Lincoln, NE) and presented as fold
changes normalized to actin. The
graph shows mean  SEM (n ¼ 6)
versus healthy control. *P < 0.05
calculated by one-way ANOVA,
followed by Tukey’s post-hoc test.
(c) Immunofluorescence staining of
COMP in healthy (left column),
psoriatic nonlesional (middle
column), and psoriatic lesional (right
column) skin. Representative images
are shown. Dotted lines indicate the
border of the dermaleepidermal
junction (n ¼ 10) (Supplementary
Figure S3). Original
magnification: 20. Bar ¼ 50 mm.
(d) RT-PCR analysis of COMP cDNA
from cultured human dermal
fibroblasts of healthy and psoriatic
nonlesional skin. Data were
normalized to 18S rRNA using the
DDCt method. The graph shows mean
 SEM (n ¼ 8) versus healthy cultured
fibroblasts. **P < 0.01, determined by
two-tailed Student t-test. COMP,
cartilage oligomeric matrix protein.
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17342010). In healthy skin, COMP is primarily produced by fi-
broblasts (Dodge et al., 1998) and localizes to the papillary
dermis, where it is believed to take part in ECM stabilization
and provide cohesion between the anchoring plaques of the
upper dermis and the BM (Agarwal et al., 2012; Farina et al.,
2006). Although COMP accumulation in the dermis is
elevated in various fibrotic skin disorders (Agarwal et al.,
2013; Inui et al., 2011), COMP has not been investigated
previously in the context of psoriasis.
COMP modulates cellular behavior via direct interactions
with cell surface proteins, including the a5b1 (Chen et al.,
2005), a7b1, and avb3 (Rock et al., 2010) members of the
integrin family. a5b1-integrin modulates processes in psori-
asis pathogenesis, including inflammatory responses and
keratinocyte proliferation (Bata-Csorgo et al., 1998; Chen
et al., 2001; Pellegrini et al., 1992).
Here we show that the COMP level is elevated in nonle-
sional psoriatic skin, where it colocalizes with a5b1-integrin
and EDA þ FN and has a suppressive effect on keratinocyte
proliferation, which is likely mediated through a5b1-integrin.
In this way, COMP can override the proliferation-promoting
effect of increased EDA þ FN and a5b1-integrin, which is
associated with the disrupted laminin layer. (Bata-CsorgoJournal of Investigative Dermatology (2020), Volume 140et al., 1998; Mondello et al., 1996). These results indicate a
crucial role for COMP in the pathomechanism of psoriasis.
RESULTS
COMP level is elevated in psoriatic nonlesional skin
Nonlesional skin carries several known alterations of the
ECM in the papillary dermis (Bos et al., 1983; Ting et al.,
2000). Because COMP previously has been reported to also
be present in the papillary dermis, COMP protein accumu-
lation was characterized in nonlesional and lesional skin
from patients with psoriasis and skin from healthy in-
dividuals. COMP protein was detected with western blot
analysis under reducing (Figure 1a and b and Supplementary
Figure S1) and nonreducing (Supplementary Figure S2) con-
ditions. Under reducing conditions, we detected elevated
COMP monomer and fragment levels in psoriatic nonlesional
protein extracts compared with healthy skin (Figure 1a and b
and Supplementary Figure S1).
Subsequently, the distribution of COMP in tissues was
analyzed using immunofluorescence staining. In line with
previous reports, COMP was detected in the papillary dermis
of healthy skin (Farina et al., 2006). In psoriatic nonlesional
samples, COMP deposition extended deeper into the dermis
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in healthy samples (Figure 1c and Supplementary Figure S3).
In contrast, COMP deposition in lesional skin extended to the
upper part of the reticular dermis and exhibited a discontin-
uously scattered distribution (Figure 1c and Supplementary
Figure S3).
Because skin fibroblasts are the major producers of COMP
protein (Dodge et al., 1998), we examined the mRNA
expression of COMP in primary dermal fibroblasts derived
from healthy and psoriatic nonlesional skin and detected
elevated COMP mRNA expression in nonlesional fibroblasts
(Figure 1d).
COMP colocalization with ITGB1 of basal keratinocytes and
EDA D FN is increased and with LAMA1 is decreased in
nonlesional psoriatic skin
COMP is known to interact with several members of the
integrin cell-surface receptor family, including a5b1-integrin
(Chen et al., 2005), whose expression increases together with
EDA þ FN in nonlesional skin, possibly owing to damaged
BM (Bata-Csorgo et al., 1998; Mondello et al., 1996; Ting
et al., 2000). To investigate the possible interactions of
COMP with proteins in the DEJ that have been altered,
confocal microscopic analysis with dual immunofluores-
cence staining was applied and consecutive sections of the
appropriate area were analyzed.
To determine whether COMP accumulation at the DEJ al-
lows interaction with basal epidermal keratinocytes, COMP
and b1-integrin (ITGB1) co-immunofluorescence staining
was applied. In the papillary dermis, COMP staining partially
colocalized with the ITGB1 from basal keratinocytes in
healthy and nonlesional skin (Figure 2a and Supplementary
Figure S4). However, the colocalization of the two proteins
was most prominent in psoriatic nonlesional skin (Figure 2d).
LAMA1 is a component of the BM laminin layer, which is
fragmented and occasionally completely missing in nonle-
sional psoriatic skin (Mondello et al., 1996; Vaccaro et al.,
2002). Therefore, to examine whether the damaged BM of
nonlesional skin allows the interaction of COMP and ITGB1,
LAMA1eCOMP dual immunostaining was performed. In
nonlesional skin, COMPeITGB1 double-positive regions
exhibited a discontinuous LAMA1 staining pattern
(Figure 2b), and the co-occurrence of COMPand LAMA1 was
significantly lower in nonlesional skin compared with healthy
skin (Figure 2e).
In addition, FN has also been reported to interact with
COMP (Di Cesare et al., 2002); therefore, confocal micro-
scopic analysis was also applied to COMP and EDA þ FN. In
psoriatic nonlesional skin, in which colocalization of COMP
and ITGB1 was apparent, partial colocalization of COMPand
EDA þ FN was observed (Figure 2c), and the intensity of
colocalization was significantly higher in nonlesional skin
relative to healthy skin (Figure 2f).
COMP negatively influences keratinocyte proliferation via
a5b1-integrin in vitro
To investigate whether the possible interaction between
COMP and ITGB1 influences keratinocyte cellular behavior,
we first performed an impedance measurementebased, real-
time cellular analysis of the HPV-KER immortalized kerati-
nocyte cell line. When the culturing plate was precoated withrecombinant human COMP (rhCOMP), cells exhibited
reduced cell index values in a manner that was dependent on
COMP concentration compared with cells grown on un-
coated surfaces (Figure 3a). Cell index is influenced by
changes in cell proliferation, viability, morphology, and
adhesion (Dickhuth et al., 2015). To investigate whether the
proliferation rate of HPV-KER cells was affected, a BrdU cell
proliferation assay was performed. Precoating the surface
with a high concentration (10 mg/ml) of rhCOMP resulted in
significantly reduced proliferation rates at 24 and 72 hours
compared with cells grown on an uncoated surface. Cell
proliferation of primary normal human epidermal keratino-
cytes was also reduced when the surface was coated with 10
mg/ml rhCOMP (Figure 3c).
To test whether integrins mediate the observed negative
effect of COMP on cell proliferation, blocking experiments
using anti-ITGA5 and anti-ITGB1 polyclonal antibodies were
performed. Blocking of either the ITGA5 or ITGB1 subunit in
cells grown on a surface precoated with 10 mg/ml rhCOMP
abolished the negative effect of COMP on HPV-KER prolif-
eration, whereas blocking either ITGA5 or ITGB1 alone had
no negative effect on these cells (Figure 4a and b and
Supplementary Figure S5). Similarly, the negative effect of
COMP on the proliferation rate of primary normal human
epidermal keratinocyte cells could also be abolished by
blocking COMP, ITGA5, or ITGB1, as determined with the
BrdU assay (Figure 4c and d) and Ki67 immunofluorescent
staining (Figure 4e and f).
COMP has a negative effect on skin wound healing by
attenuating keratinocyte proliferation and by compromising
keratinocyte migration and activation in ex vivo wound
models
To further study the effect of COMP on keratinocytes, an
ex vivo three-dimensional skin wound-healing model was
applied. Standardized wounded skin samples, with or
without rhCOMP treatment (10 mg/ml) (Figure 5a), and un-
wounded controls were examined at 72 hours after wound-
ing. Immunofluorescent staining revealed COMP localization
on the dermal surface of the injured region in COMP-treated
wounds, whereas COMP was not detected at the injured
region of untreated wounds 72 hours after treatment
(Figure 5a). By applying Ki67 immunofluorescent staining to
detect proliferating cells, we found a markedly reduced
number of Ki67-positive cells in COMP-treated wounds,
indicating a decreased rate of proliferation (Figure 5b and c,
Supplementary Figure S6a).
Cell migration processes at the wound edge during the
closure of injuries require dynamic reorganization of the
actin cytoskeleton in the keratinocytes located close to
wound margins. To visualize these cells, immunofluores-
cence staining for actin was applied. In wounds not exposed
to COMP, we found that keratinocytes exhibited high levels
of actin expression at wound edges, whereas actin expression
at wound edges was markedly decreased in COMP-treated
wounds, indicating that actin expression was compromised,
possibly resulting in a reduction of active cell migration
(Figure 5d).
Keratin 17 (KRT17) expression is known to be induced in
keratinocytes at wound edges during healing (Mazzalupowww.jidonline.org 1735
Figure 2. COMP colocalization with
basal keratinocyte b1-integrin and
EDA D FN increases and with
LAMA1 decreases in nonlesional
psoriatic skin. Confocal microscopic
immunofluorescence analysis of (a)
COMP and b1-integrin, (b) COMP and
LAMA1, and (c) COMP and EDA þ FN
colocalization in healthy (first row)
and psoriatic nonlesional (second
row) skin. Representative images are
shown. Dotted lines indicate the
enlarged regions. Colocalized pixels
of the indicated proteins were
calculated with ImageJ software
(n ¼ 5). Original magnification: 63.
Bar ¼ 10 mm. The extent of
colocalization of (d) COMP and
b1-integrin, (e) COMP and LAMA1,
and (f) COMP and EDA þ FN was
calculated using ImageJ/Fiji software.
The graphs show mean Pearson’s
correlation coefficient R  SEM (n ¼ 5)
versus healthy control. *P < 0.05,
**P < 0.01 determined by two-tailed
Student t-test. EDAþ FN, fibronectin
splice variant containing extra domain A.
COMP, cartilage oligomeric matrix
protein.
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Figure 3. COMP negatively influences keratinocyte cell proliferation. (a) CI measurement of HPV-KER cells cultured on surfaces that were uncoated or coated
with rhCOMP (1 and 10 mg/ml). CI was determined using real-time impedance measurementebased cellular analysis. The graph is representative of four
independent experiments, all showing similar results. The graph shows mean CI  SEM of four technical replicas for each group, *P < 0.05 versus uncoated
control, #P < 0.05 versus 1 mg/ml rhCOMP-coated group calculated by one-way ANOVA, followed by Tukey’s post-hoc test. BrdU cell proliferation assay of
(b) HPV-KER and (c) NHEK cells cultured on uncoated and rhCOMP protein (1 and 10 mg/ml)-coated surfaces at 24 and 72 hours following seeding. The graphs
show mean proliferation  SEM (n ¼ 3). **P < 0.01, calculated by one-way ANOVA followed by Tukey’s post-hoc test. CI, cell index; COMP, cartilage
oligomeric matrix protein; NHEK, normal human epidermal keratinocyte; rhCOMP, recombinant human COMP.
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orescence staining to further investigate the effect of
COMP in the ex vivo wound healing model. In rhCOMP-
treated wounds, KRT17 expression and re-epithelization
were reduced and restricted to a smaller proportion of
keratinocytes, compared with untreated control wounds
(Figure 5e and Supplementary Figure S6b and c). This
suggests that the presence of COMP compromised kerati-
nocyte activation.
DISCUSSION
In psoriasis, the nonlesional skin contains ECM alterations
compared with healthy skin. COMP is localized to the
papillary dermis of healthy skin (Farina et al., 2006) and,
through its interactions with type XII and XIV collagens,
contributes to the stabilization of the DEJ (Agarwal et al.,
2012). We found that, in psoriatic nonlesional skin, COMP
is localized to the papillary dermis and, in contrast to healthy
skin, it forms a continuous, more compact, linear layer
beneath the basal keratinocytes. Apart from this altered
localization, COMP expression was also elevated in dermal
fibroblasts from psoriatic samples.
Psoriatic nonlesional skin is more sensitive to stress
(Sonkoly et al., 2005; Széll et al., 2016), and abnormalities at
the DEJ and the BM are believed to be important in the
development of the disease (Bos et al., 1983; Ting et al.,
2000). Interruption of the BM (Mondello et al., 1996;
Vaccaro et al., 2002) may allow ECM components, nor-
mally located directly below the BM, to come in direct
contact with basal keratinocytes. COMP reportedly binds
directly to the extracellular domain of ITGB1 of both car-
diomyocytes (Huang et al., 2013) and cardiac fibroblasts,resulting in the stabilization of ITGB1 by preventing its
degradation and, subsequently, improving cellular survival
(Huang et al., 2013; Posey et al., 2018). In cartilage, COMP
mediates chondrocyte attachment and stabilization partially
via a5b1-integrin (Tan et al., 2009). Our confocal micro-
scopic analysis revealed a partial colocalization of papillary
dermal COMP and ITGB1 in basal keratinocytes, which in-
dicates the possibility of a direct interaction between these
two proteins in vivo. In nonlesional skin, the a5-integrin
(ITGA5) subunit is overexpressed in the basal layer of the
epidermis, in contrast to healthy skin, where it is present at
low levels or completely missing (Bata-Csorgo et al., 1998).
Our findings are in line with this observation, as COMP and
ITGB1 strongly colocalize in psoriatic nonlesional epidermis
and expression of both are upregulated in nonlesional skin.
Moreover, the BM is partially discontinuous in psoriatic
nonlesional skin (Mondello et al., 1996; Vaccaro et al.,
2002), allowing direct interaction. The possibility of this
interaction is supported by our finding that, in areas where
COMP and ITGB1 were found to have strong colocalization
in psoriatic nonlesional skin, the expression of LAMA1, a
member of the BM, is reduced or completely absent.
COMP also interacts with a7b1- and avb3-integrins (Chen
et al., 2005; Rock et al., 2010). Of these proteins, only a7b1
contains a ITGB1 subunit. There is currently no information
available about a7b1-integrin expression in basal keratino-
cytes. Thus, we assumed that, if COMP exhibits a strong
interaction with ITGB1, its a-subunit is likely to be ITGA5.
In addition to binding to a5b1-integrin, an FN receptor,
COMP might also bind to the FN protein itself (Di Cesare
et al., 2002). Furthermore, a5b1-integrineassociated FN
and EDA þ FN are known to play roles in psoriasiswww.jidonline.org 1737
Figure 4. COMP influences keratinocyte proliferation via a5b1 integrin. (a, b) BrdU cell proliferation assay of HPV-KER cells cultured on surfaces that were
uncoated or coated with rhCOMP protein (10 mg/ml) for 24 and 72 hours following seeding and treated with (a) antiea5-integrin or (b) antieb1-integrin subunit
antibodies. (c, d) BrdU assay and (e, f) Ki67-positive proliferating cell number determination of NHEKs grown on surfaces that were uncoated or coated
with rhCOMP protein (10 mg/ml) for 72 hours following seeding and treated with (c, e) antiea5-integrin and (d, f) antieb1-integrin subunit antibody in a
combination with COMP protein neutralization. The graphs show mean proliferation/mean number of Ki67-positive cells  SEM (n ¼ 3) versus uncoated
control, *P < 0.05, **P < 0.01 calculated by one-way ANOVA, followed by Tukey’s post-hoc test. COMP, cartilage oligomeric matrix protein; NHEK, normal
human epidermal keratinocyte; rhCOMP, recombinant human COMP.
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Figure 5. COMP has a negative effect on keratinocyte proliferation and is involved in keratinocyte migration and activation in ex vivo wound models.
(a) Representative images of the ex vivo skin wound healing models (n ¼ 3; magnification 4; Bar¼ 250 mm). Immunofluorescent staining for COMPat wound edges
and at the middle of the wounds of untreated controls and wounds treated with rhCOMP (n ¼ 3; magnification 20; Bar ¼ 50 mm). Immunostaining for (b) Ki67, (d)
actin, or (e) keratin-17 in the ex vivo unwounded skin (left column), and wound-healing skin models with (right column) and without (middle column) rhCOMP
treatment. Representative images are shown. Dotted lines indicate the border of the dermaleepidermal junction (n ¼ 3; magnification 20; bar ¼ 50 mm). (c) Ki67-
positive cells in wounds that were not treated and were treated with rhCOMP protein. The graph shows mean number of Ki67-positive cells  SEM (n ¼ 3) versus
uncoated, untreated control **P < 0.01 determined by two-tailed Student t-test. COMP, cartilage oligomeric matrix protein; rhCOMP, recombinant human COMP.
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Enriched expression of a5b1-integrin and EDA þ FN in
nonlesional skin is thought to be due to the incompleteness
of the laminin layer (Mondello et al., 1996; Vaccaro et al.,
2002). Our confocal microscopic analysis revealed partial
colocalization of COMP and EDA þ FN in nonlesional skin.
These results suggest that, in addition to interacting with
EDA þ FN, COMP may also affect basal keratinocytes via
interactions with both the EDA þ FN and its receptor, a5b1-
integrin.
Keratinocyte behavior is influenced by ECM proteins
through interactions with different cell surface integrins
(Hamill et al., 2012; Tjin et al., 2014), and connection of
basal keratinocytes to the altered BM could enhance prolif-
eration (Yang et al., 2016). We analyzed the biological rele-
vance of the interaction of COMP and ITGB1 in basalkeratinocytes using HPV-KER and normal human epidermal
keratinocyte cells in vitro. We found that the presence of
COMP resulted in reduced keratinocyte proliferation in both
cell types and that this affect was reversible by blocking
COMP with a specific antibody.
We also analyzed whether the observed negative effect of
COMP on keratinocyte proliferation involves interaction with
a5b1-integrin. By partially blocking the function of the
ITGB1 or ITGA5 subunits with specific antibodies, the
negative effect of COMP on cell proliferation was abolished,
suggesting that the negative influence of COMP on kerati-
nocyte proliferation involves a5b1-integrin.
Our in vitro findings were also validated in an ex vivo
wound model; exogenous COMP treatment delayed healing
of artificial wounds, and this affect was coupled with reduced
keratinocyte proliferation and compromised actin expression,www.jidonline.org 1739
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1740both important aspects of wound healing (Gurtner et al.,
2008). In addition, keratinocyte KRT17 expression, consid-
ered a hallmark of normal wound healing (Mazzalupo et al.,
2003), was also decreased in the presence of COMP. These
results suggest that COMP has a negative influence on ex vivo
wound healing. In normally healing wounds of healthy do-
nors, COMP was hardly detectable when re-epithelialization
was complete (Agarwal et al., 2013). Similarly, in psoriatic
lesions, in which keratinocyte proliferation is abnormally
increased, COMP was found to be discontinuous or
completely absent from the papillary dermis. Although there
are no data regarding keratinocyte proliferation or migration
in wounds of COMP-deficient mice (Schulz et al., 2016), in
human nonhealing wounds, such as venous leg ulcers, the
level of COMP is reported to be highly elevated (Agarwal
et al., 2013). Our findings are in agreement with this
observation.
In conclusion, our study shows that COMP is present at
an elevated level in the papillary dermis of nonlesional
psoriatic skin and that it possibly reduces keratinocyte
proliferation via the a5b1-integrin. These aspects of COMP
contribute to the maintenance of the nonlesional, non-
hyperproliferative state of psoriatic nonlesional epidermis,
despite the overexpression of EDA þ FN and ITGA5. Similar
interactions may also take place in other skin diseases in
which nonhealing wounds are coupled with massive COMP
accumulation.
MATERIALS AND METHODS
Skin samples and ethics
Skin punch biopsies (diameter ¼ 6 mm) were collected from healthy
volunteers (n ¼ 10; age 18e70 years, Supplementary Table S1), and
from patients with psoriasis with moderate-to-severe chronic plaque-
type psoriasis from lesional (n ¼ 13) and nonlesional skin areas (n ¼
13; minimum of 6 cm from lesional region; age 18e70 years
[Supplementary Table S1]). Patients with psoriasis did not receive
local therapy for at least 4 weeks and had not been subjected to
systemic therapy for at least 8 weeks. Skin biopsies were taken from
areas of skin that were not exposed to sun. Tissue collection was
obtained after written informed consent, in accordance with the
rules of the Helsinki Declaration. The study was confirmed by the
Human Investigation Review Board of the University of Szeged
(PSO-EDAFN-002, 34/2015, 3517, 23 February 2015, Szeged,
Hungary; PSO-ECMPR-002 IF-562-5/2016 and 157/2015-SZTE,
3638, 21 September 2015, Hungary).
Fluorescence microscopic analysis
Biopsies were frozen in a cryogenic matrix (Thermo Fisher Scien-
tific, Waltham, MA) or were paraffin embedded and were subse-
quently cut into 5-mm sections. For fixation and permeabilization,
4% paraformaldehyde followed by 0.25% TritonX-100 (Thermo
Fisher Scientific) or commercially available staining buffer set
(eBioscience, Santa Clara, CA) were used. For blocking, Tris-
buffered saline containing 1% bovine serum albumin and 1%
normal goat serum (Sigma-Aldrich, St. Louis, MO) was used, and
for frozen samples, which were digested with chondroitinase ABC
(5U, 1:100; Sigma-Aldrich), 10% fetal bovine serum (EuroClone,
Pero, Italy) and 5% normal goat serum (Sigma-Aldrich) were
applied. Samples were incubated with the following primary anti-
bodies: polyclonal rabbit anti-human COMP (1:250), a kind giftJournal of Investigative Dermatology (2020), Volume 140from Mats Paulsson and Frank Zaucke from the University of Co-
logne (Agarwal et al., 2012); mouse anti-human ITGB1 (clone:
JB1B, 1:100, Abcam, Cambridge, United Kingdom); rabbit anti-
human actin (1:100, Sigma-Aldrich); mouse anti-human Ki67
(1:100, Beckton Dickinson, Franklin Lakes, NJ); mouse anti-human
KRT17 (ready to use, Dako, Santa Clara, CA); mouse anti-human
LAMA1 (clone: LAM-89, 1:100, R&D Systems, Minneapolis, MN);
and mouse anti-human FN (EDA þ FN, clone: IST-9, 1:500,
Abcam). Isotype controls were the following: rabbit polyclonal IgG
(Santa Cruz Biotechnology, Dallas, TX) and mouse IgG1 (Beckton
Dickinson) antibodies. As secondary antibodies, Alexa Fluor
546econjugated anti-rabbit IgG and Alexa Fluor 647econjugated
anti-mouse IgG (Life Technologies, Carlsbad, CA) were used.
Nuclei were visualized with DAPI (Sigma-Aldrich) staining. Zeiss
LSM 880 or Zeiss Axio Imager Z1 microscopes (Carl Zeiss AG,
Oberkochen, Germany) were used for visualization.
Pearson’s correlation coefficient, R, was calculated using ImageJ/
Fiji software.
Cell cultures and examination of cellular properties
Cell proliferation assay. To investigate the effect of COMP on
keratinocyte proliferation, a BrdU cell proliferation colorimetric
ELISA assay (Abcam) was performed. HPV-KER cells, a stable hu-
man keratinocyte cell line that has been characterized in our lab-
oratory (Danis et al., 2018; Erdei et al., 2018; Tax et al., 2016), and
normal human epidermal keratinocyte cells were plated at a den-
sity of 10,000 cells per well in 96-well plates (Corning, NY) that
were uncoated or coated with low- (1 mg/ml) or high-concentration
(10 mg/ml) rhCOMP protein (R&D Systems), in three technical
replicates. For the blocking of ITGA5 and ITGB1, the following
antibodies (1 mg antibody for 106 cells) were used: mouse anti-
human ITGA5 antibody (clone: IIA1, Beckton Dickinson) and
mouse anti-human ITGB1 (clone: JB1B). Goat anti-human COMP
antibody (1 mg antibody for 10 mg/ml rhCOMP protein, R&D Sys-
tems) was applied to block the COMP protein. Integrin- and
COMP-blocking was applied to cells grown on uncoated plates or
plates coated with 10 mg/ml rhCOMP protein. BrdU assay was
performed at 24 and 72 hours after blocking, according to the
manufacturer’s instructions.
Ex vivo skin wound-healing assay
Healthy skin samples were collected for the ex vivo organotypic
wound healing assay. Approximately 1-cm diameter skin pieces
were cut and mildly wounded in the middle using a 4-mm punch
biopsy blade (Steele Supply Company, St. Joseph, MI). Wounded
skin samples and unwounded control samples were incubated for
72 hours at an aireliquid interface on the upper part of transwell
cell culture inserts. The dermal part was in contact with DMEM
F12 culture media (Lonza Group, Basel, Switzerland) supple-
mented with 10% fetal bovine serum (EuroClone) and 1% anti-
biotic/antimycotic solution (Sigma-Aldrich). The middle of the
wounds was treated for 72 hours with high-concentration (10 mg/
ml) rhCOMP (R&D Systems) diluted in PBS or PBS only as a
control. Samples were fixed in formalin and embedded in paraffin
for immunofluorescent staining. To determine the rate of prolifer-
ation, 50 cells on each wound edge were counted and the pro-
portion of Ki67-positive cells was determined. Re-epithelization of
untreated, control (where only PBS was administered), and COMP-
treated wounds were assessed by measuring the area using the
ImageJ software.
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For comparing only two groups, two-tailed Student t-test was per-
formed. One-way ANOVA with Tukey post-hoc test was used to
compare more than two groups. Differences were considered sta-
tistically significant at **P < 0.01, *P < 0.05. Data were analyzed
using R-Studio software, version 3.2.2 (R-Studio, Boston, MA).
Further methods
More detailed information of the materials and methods regarding
protein isolation and western blot analysis, cell culture experiments,
H&E staining, RNA isolation, and real-time PCR are presented in the
Supplementary Materials.
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Foundation (H-1103 Budapest, Gyömr}oi str. 19-21.). The study took place
in Szeged, Hungary.
AUTHOR CONTRIBUTIONS
Conceptualization: GG; Formal Analysis: RB, KS, GG; Investigation: RB, ES,
JD, BG; Methodology: RB, GG; Supervision: LK, ZBC, GG; Writing - Original
Draft Preparation: RB, GG; Writing - Review and Editing: KS, ZBC, GG.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at www.
jidonline.org and at https://doi.org/10.1016/j.jid.2019.12.037.
REFERENCES
Agarwal P, Schulz JN, Blumbach K, Andreasson K, Heinegård D,
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Protein isolation and western blot analysis
For preparation of tissue protein extracts, skin biopsies
(healthy, psoriatic nonlesional, and psoriatic lesional) were
cut into small pieces with a razor blade. Guanidine hydro-
chloride (6 M, Sigma-Aldrich, St. Louis, MO) solution was
used as an extraction buffer for 24 hours at 4 C under
continuous agitation. For protein precipitation, an ethanol-
based method was applied. Protein concentrations were
measured using Bradford assay (Bio-Rad Laboratories, Her-
cules, CA). Protein extracts (25 mg) were separated on a
4e20% gradient SDS polyacrylamide gel under reducing or
nonreducing conditions. Proteins were transferred to a
nitrocellulose membrane (Bio-Rad Laboratories) and blocked
in 5% nonfat milk powder containing Tris-buffered saline for
60 minutes at room temperature. Membranes were incubated
for overnight at 4 C with goat anti-human COMP primary
antibody (1:2,000, R&D Systems, Minneapolis, MN), and
rabbit anti-human actin primary antibody (1:2,000, Sigma-
Aldrich). Subsequently, membranes were incubated with
horseradish peroxidaseeconjugated anti-goat (Thermo Fisher
Scientific, Waltham, MA), and anti-rabbit (Southern Biotech,
Birmingham, AL) secondary antibodies, both diluted 1:2,000
for 60 minutes at room temperature. Signal was visualized
with Clarity Max Western ECL Substrate (Bio-Rad Labora-
tories) on a C-digit blot scanner (LI-COR Biosciences,
Lincoln, NE).
H&E staining and light microscopic analysis
To visualize the tissue structure of ex vivo wound model
samples, H&E (Leica Biosystems, Wetzlar, Germany) staining
was performed according to the manufacturer’s instructions
in a Leica ST5020 Multistainer device (Leica Biosystems). The
stained samples were visualized with a Nikon eclipse TS100
microscope (Nikon, Minato, Tokyo, Japan).
Cell cultures and examination of cellular properties
Cell cultures. Primary dermal fibroblasts were isolated
from healthy and psoriatic nonlesional skin biopsies, and
normal human epidermal keratinocytes (NHEKs) were iso-
lated from healthy skin samples. The epidermis was separated
from the dermis with overnight incubation at 4 C in Dispase
II (neutral protease, grade II, 2 U/ml, Roche Diagnostics,
Basel, Switzerland) (Szabad et al., 2007) solution. Keratino-
cytes were obtained from the epidermal part after trypsin
digestion for 10 minutes at 37 C (Sigma-Aldrich). NHEK
cells were then grown in keratinocyte serum-free medium
(Life Technologies, Carlsbad, CA) supplemented with 1%
antibiotic/antimycotic solution (Sigma-Aldrich), brain pitui-
tary extract (50 mg/ml, Life Technologies), and epidermal
growth factor (5 ng/ml, Life Technologies).
Fibroblasts were obtained from the dermal part after
digestion for 120 minutes at 37 C. The medium, DMEM
supplemented with 1 g/liter glucose (Lonza Group, Basel,
Switzerland), also contained collagenase (from Clostridium
histolyticum, 2.7 mg/ml, Sigma-Aldrich), deoxyribonuclease
I (from bovine pancreas, 0.1 mg/ml, Sigma-Aldrich), hyal-
uronidase (from bovine testes, 1.25 mg/ml, Sigma-Aldrich),
and fetal bovine serum (2.5%, EuroClone, Pero, Italy)
(Gubán et al., 2016). Fibroblasts were cultured in DMEMwith 1 g/liter glucose (Lonza Group), supplemented with 5%
fetal bovine serum (EuroClone), 1% antibiotic/antimycotic
solution (Sigma-Aldrich), and 1% L-glutamine (PAA Labora-
tories GmbH, Pasching, Austria).
The human immortalized keratinocyte cell line HPV-KER
was also used for our experiments. HPV-KER is a stable cell
line, generated from NHEKs transfected with the HPV16/E6
oncogene in a pCMV vector. It was established by continuous
culturing (Tax et al., 2016). It shows similar responses to
NHEK cells in various immune activation protocols (Danis
et al., 2018; Erdei et al., 2018). Culture conditions of HPV-
KER cells are the same as NHEK cells. Each cell type was
cultured at 37 C in a humidified atmosphere with 5% v/v
CO2.
Real-time, label-free cellular analysis of HPV-KER cells
using the xCELLigence system. xCELLigence (ACEA Bio-
sciences, San Diego, CA) is a real-time, impedance
measurementebased cellular analysis system, where
dimensionless cell index value is calculated (cell index ¼
[impedance at time point n e impedance in the absence of
cells]/nominal impedance value). Differences in cell index
values could be due to altered cell proliferation rate, viability,
morphology, and adhesion (Dickhuth et al., 2015). This sys-
tem was used to investigate the effect of the COMP protein on
keratinocytes. HPV-KER cells were plated at a density of
10,000 cells per well in uncoated 96-well E-plates (ACEA
Biosciences) or wells that were coated with low-
concentration (1 mg/ml) or high-concentration (10 mg/ml)
recombinant human COMP protein (R&D Systems). Imped-
ance measurement was performed every 15 minutes for 140
hours, and a dimension-free cell index value was calculated
for every time point. Four technical replicates were
performed.
Further investigation of keratinocyte cell proliferation. To
further investigate the effect of COMP on the proliferation of
NHEK cells, Ki67 immunofluorescent staining (mouse anti-
human Ki67 antibody, 1:100, Beckton Dickinson, Franklin
Lakes, NJ) was applied, using integrin and COMP-blocking as
described in the main text. Cells were plated at a density of
20,000 cells per well in 8-well chamber slides (SPL Life
Sciences, Naechon-Myeon, Pocheon-si, Korea) that were
uncoated or coated with high-concentration (10 mg/ml) re-
combinant human COMP (R&D Systems) in three biological
replicates. Ki67-positive cells were counted on three
randomly selected areas per group, and statistical analysis
was performed.
RNA isolation and real-time PCR. Total RNA was isolated
from primary fibroblasts from healthy and psoriatic nonle-
sional skin cultured in 75-cm2 cell culture flasks (Corning,
NY) and collected at the fifth passage using TRI-Reagent
(Molecular Research Center, Cincinnati, OH) as described
by the manufacturer. The iScript cDNA Synthesis kit (Bio-Rad
Laboratories) was used for cDNA synthesis, and 0.5 mg total
RNA was reverse transcribed. RT-PCR was performed on a
C1000 Touch Thermal Cycler (Bio-Rad Laboratories) with
the Universal Probe Library system (Roche Diagnostics)
using qPCRBIO Probe Mix Lo-ROX (PCR Biosystem Ltd.,
London, United Kingdom) and the following primers:www.jidonline.org 1742.e1
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1742.e2COMP FWD: CACCGACGTCAACGAGTG, COMP REV:
TGGTGTTGATACAGCGGACT; 18S rRNA FWD: CGCTCCAC
CAACTAAGAACG, 18SrRNA REV: CTCAACACGGGAAACC
TCAC. The expression of COMP was normalized to 18S rRNA
expression using the DDCt method.SUPPLEMENTARY REFERENCES
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Supplementary Figure S1. COMP monomer and fragment level is elevated
in psoriatic nonlesional skin under reducing conditions. COMP monomers
and fragments were detected with western blot analysis from healthy,
psoriatic nonlesional, and lesional skin under reducing conditions (n ¼ 3).
The band intensities of (a) COMP monomer and (b) COMP fragment
separately, as well as (c) the level of monomer and fragment together were
analyzed with Image Studio software (LI-COR Biosciences) and presented as
fold changes normalized to actin. The graph shows mean  SEM (n ¼ 3),
*P < 0.05 versus healthy control, calculated by one-way ANOVA followed by
Tukey’s post-hoc test. COMP, cartilage oligomeric matrix protein.
Supplementary Figure S2. COMP protein detection under nonreducing
conditions. COMP protein was detected with western blot analysis from
healthy, psoriatic nonlesional, and lesional skin under nonreducing
conditions (n ¼ 3). A representative blot is shown. COMP, cartilage
oligomeric matrix protein; H, healthy; L, lesional; NL, nonlesional.
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Supplementary Figure S3.
Characterization of COMP deposition
in healthy, nonlesional, and lesional
skin. Immunofluorescence staining for
COMP in (a) healthy, (b) psoriatic
nonlesional, and (c) psoriatic lesional
skin (n ¼ 10). Zeiss Axio Imager Z1
original magnification, 20. Bar ¼ 50
mm. COMP, cartilage oligomeric
matrix protein.
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Supplementary Figure S4. Enhanced
colocalization of COMP with b1-
integrin in nonlesional psoriatic skin.
Confocal microscopic
immunofluorescence analysis of
COMP and b1-integrin in (a) healthy
and (b) psoriatic nonlesional skin
using z-stack pictures. Dotted lines
indicate the borders of enlarged
regions. Colocalized pixels of COMP
and b1-integrin were calculated by
ImageJ software (n ¼ 5). Original
magnification, 63. Bar ¼10 mm.
COMP, cartilage oligomeric matrix
protein.
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Supplementary Figure S5. COMP
negatively influences keratinocyte CI
via a5b1-integrin. CI measurement of
HPV-KER cells cultured on uncoated
and rhCOMP-coated (10 mg/ml)
surfaces. CI was determined using
real-time impedance measuremente
based cellular analysis. The graph is
representative of three independent
experiments, all showing similar
results. Mean CI  SEM of four
technical replicas for each group. CI,
cell index; COMP, cartilage
oligomeric matrix protein; rhCOMP,
recombinant human COMP.
Supplementary Figure S6. Reduced
proliferation and re-epithelization in
the presence of COMP during ex vivo
skin wound healing. (a) Reduced
number of Ki67-positive cells was
detected in wound samples treated
with rhCOMP (10 mg/ml) compared
with untreated control wounds. The
graph shows mean  SEM (n ¼ 3),
*P < 0.05 versus untreated control,
calculated by two-tailed Student t-test.
(b) Re-epithelization of artificial
untreated and rhCOMP-treated (10
mg/ml) wounds on H&E-stained
sections (n ¼ 3). Original
magnification, 20. Bar ¼ 50 mm.
Representative pictures are shown.
Arrowheads indicate the newly
synthetized areas. (c) Re-
epithelization of untreated and
control- and rhCOMP-treated wounds
was measured using area
measurement of ImageJ software. The
graph shows mean  SEM (n ¼ 3),
*P < 0.05 versus untreated control,
calculated by two-tailed Student t-test.
COMP, cartilage oligomeric matrix
protein; rhCOMP, recombinant
human COMP.
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Supplementary Table S1. Donor Data and Experiments Applied to Donor Samples
Donor Information Experimental Application List of Donor Samples
Donor Groups Donor ID Sex Age PASI score
Figure 1b (Western
Blot Analysis) Figure 1c (IF)
Figure 1d
(RT-PCR)
Used for
Figure 2
Plaque-type psoriasis PS1 male 66 17.1 þ þ — þ
PS2 male 52 5.5 þ þ — —
PS3 male 61 12 — þ — þ
PS4 male 55 12.1 þ þ — þ
PS5 male 70 5.9 — þ — —
PS6 male 53 21.2 þ þ þ þ
PS7 male 67 17.8 — þ þ þ
PS8 male 40 19.6 þ þ þ —
PS9 male 69 12.4 þ þ þ —
PS10 male 70 9.8 — þ þ —
PS11 male 69 11.5 — — þ —
PS12 male 60 4.1 — — þ —
PS13 male 63 26.4 — — þ —
Healthy H1 male 39 n/a þ þ þ —
H2 male 29 n/a þ þ — —
H3 male 37 n/a — þ þ —
H4 male 48 n/a þ þ þ þ
H5 male 53 n/a þ þ þ þ
H6 male 51 n/a þ þ þ þ
H7 male 46 n/a — þ þ þ
H8 male 61 n/a þ þ þ þ
H9 male 37 n/a — þ þ —
H10 male 39 n/a — þ — —
Abbreviations: IF, immunofluorescence; n/a, not applicable.
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